{"id":219663,"date":"2026-03-04T04:51:00","date_gmt":"2026-03-04T09:51:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/03\/04\/technology-enabled-insights-into-slc-transporters-in-mafld-redefining-the-multi-hit-pathogenesis-and-therapeutic-landscape\/"},"modified":"2026-03-04T05:00:12","modified_gmt":"2026-03-04T10:00:12","slug":"technology-enabled-insights-into-slc-transporters-in-mafld-redefining-the-multi-hit-pathogenesis-and-therapeutic-landscape","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/03\/04\/technology-enabled-insights-into-slc-transporters-in-mafld-redefining-the-multi-hit-pathogenesis-and-therapeutic-landscape\/","title":{"rendered":"Technology-enabled insights into SLC transporters in MAFLD: redefining the multi-hit pathogenesis and therapeutic landscape"},"content":{"rendered":"

Technology-enabled insights into SLC transporters in MAFLD: redefining the multi-hit pathogenesis and therapeutic landscape<\/a><\/p>\n

https:\/\/www.nature.com\/articles\/s41401-026-01756-2<\/a><\/p>\n

Publish Date: 2026-03-04 04:51:00<\/a><\/p>\n

Source Domain: www.nature.com<\/a><\/p>\n

  • \n

    Chen H, Zhou Y, Hao H, Xiong J. Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies. Chin J Nat Med. 2024;22:724\u201345.<\/p>\n

    CAS\u00a0
    \n PubMed\u00a0<\/p>\n

    Google Scholar\u00a0\n <\/p>\n<\/li>\n

  • \n

    Cartland SP, Harith HH, Genner SW, Dang L, Cogger VC, Vellozzi M, et al. Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice. Sci Rep. 2017;7:1898.<\/p>\n

    Article\u00a0
    \n PubMed\u00a0
    \n PubMed Central\u00a0<\/p>\n

    Google Scholar\u00a0\n <\/p>\n<\/li>\n

  • \n

    Grander C, Grabherr F, Tilg H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc Res. 2023;119:1787\u201398.<\/p>\n

    Article\u00a0
    \n CAS\u00a0
    \n PubMed\u00a0
    \n PubMed Central\u00a0<\/p>\n

    Google Scholar\u00a0\n <\/p>\n<\/li>\n

  • \n

    Carnagarin R, Tan K, Adams L, Matthews VB, Kiuchi MG, Marisol Lugo Gavidia L, et al. Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a condition associated with heightened sympathetic activation. Int J Mol Sci. 2021;22:4241.<\/p>\n<\/li>\n

  • \n

    Feng G, Targher G, Byrne CD, Yilmaz Y, Wai-Sun Wong V, Adithya Lesmana CR, et al. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. JHEP Rep. 2025;7:101271.<\/p>\n

    Article\u00a0
    \n PubMed\u00a0<\/p>\n

    Google Scholar\u00a0\n <\/p>\n<\/li>\n

  • \n

    Fan H, Wang R, Wen B, Xiong J. Biomarkers and potential therapeutic targets driving progression of non-alcoholic steatohepatitis to hepatocellular carcinoma predicted through transcriptomic analysis. Front Immunol. 2024;15:1502263.<\/p>\n

    Article\u00a0
    \n CAS\u00a0
    \n PubMed\u00a0
    \n PubMed Central\u00a0<\/p>\n

    Google Scholar\u00a0\n <\/p>\n<\/li>\n

  • \n

    Xu Q, Feng M, Ren Y, Liu X, Gao H, Li Z, et al. From NAFLD to HCC: advances in noninvasive diagnosis. Biomed Pharmacother. 2023;165:115028.<\/p>\n

    Article\u00a0
    \n PubMed\u00a0<\/p>\n

    Google Scholar\u00a0\n <\/p>\n<\/li>\n

  • \n

    Esler WP, Bence KK. Metabolic targets in nonalcoholic fatty liver disease. Cell Mol Gastroenterol Hepatol. 2019;8:247\u201367.<\/p>\n

    Article\u00a0
    \n …<\/p>\n<\/li>\n

    Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    Technology-enabled insights into SLC transporters in MAFLD: redefining the multi-hit pathogenesis and therapeutic landscape https:\/\/www.nature.com\/articles\/s41401-026-01756-2…<\/p>\n","protected":false},"author":1,"featured_media":219664,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/media.springernature.com\/m685\/springer-static\/image\/art%3A10.1038%2Fs41401-026-01756-2\/MediaObjects\/41401_2026_1756_Fig1_HTML.png","fifu_image_alt":"","footnotes":""},"categories":[8],"tags":[66],"class_list":["post-219663","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-emerging"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/219663"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=219663"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/219663\/revisions"}],"predecessor-version":[{"id":219665,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/219663\/revisions\/219665"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/219664"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=219663"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=219663"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=219663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}